10-K Decoder · All companies

Compass Therapeutics, Inc.

CMPX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$850K−100%
Operating income−$72.8M−$56.6M−28.6%
Net income−$66.5M−$49.4M−34.6%

Questions

What was Compass Therapeutics's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), −100% vs $850K a year earlier, per its 10-K filed Mar 2026.
Was Compass Therapeutics profitable in FY2025?
No: net income was −$66.5M and operating income −$72.8M in FY2025.